7255-3861 Screening compound: N-(5-{[2-(morpholin-4-yl)-2-oxoethyl]sulfanyl}-1,3,4-thiadiazol-2-yl)-2-(2-oxo-2,3-dihydro-1,3-benzothiazol-3-yl)acetamide

7255-3861 Screening compound: N-(5-{[2-(morpholin-4-yl)-2-oxoethyl]sulfanyl}-1,3,4-thiadiazol-2-yl)-2-(2-oxo-2,3-dihydro-1,3-benzothiazol-3-yl)acetamide
7255-3861 Screening compound: N-(5-{[2-(morpholin-4-yl)-2-oxoethyl]sulfanyl}-1,3,4-thiadiazol-2-yl)-2-(2-oxo-2,3-dihydro-1,3-benzothiazol-3-yl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 7255-3861
N-(5-{[2-(morpholin-4-yl)-2-oxoethyl]sulfanyl}-1,3,4-thiadiazol-2-yl)-2-(2-oxo-2,3-dihydro-1,3-benzothiazol-3-yl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

7255-3861

Molecular Formula

C17H17N5O4S3 (C17 H17 N5 O4 S3)

Compound Name

N-(5-{[2-(morpholin-4-yl)-2-oxoethyl]sulfanyl}-1,3,4-thiadiazol-2-yl)-2-(2-oxo-2,3-dihydro-1,3-benzothiazol-3-yl)acetamide

IUPAC name

N-(5-{[2-(morpholin-4-yl)-2-oxoethyl]sulfanyl}-134-thiadiazol-2-yl)-2-(2-oxo-23-dihydro-13-benzothiazol-3-yl)acetamide

SMILES

O=C(CN(c(cccc1)c1S1)C1=O)Nc1nnc(SCC(N2CCOCC2)=O)s1

InChI

InChI=1S/C17H17N5O4S3/c23-13(9-22-11-3-1-2-4-12(11)28-17(22)25)18-15-19-20-16(29-15)27-10-14(24)21-5-7-26-8-6-21/h1-4H,5-10H2,(H,18,19,23)

InChI Key

XNZHTWJPCSMHLO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD06758722

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

451.55

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.969

Distribution Coefficient, logD

1.968

Water Solubility, LogSw

-2.46

Polar Surface Area

85.896

Acid Dissociation Constant (pKa)

9.93

Base Dissociation Constant (pKb)

-1.37

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

35.30

7255-3861 in Drug Discovery

Included in Screening Libraries

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with 7255-3861 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 7255-3861?
Check Price and Availability of 7255-3861, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 7255-3861 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 7255-3861
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 7255-3861
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 7255-3861 available by request